<DOC>
	<DOCNO>NCT01424670</DOCNO>
	<brief_summary>The purpose trial determine whether delamanid effective treatment Multidrug-resistant Tuberculosis ( MDR TB ) combination MDR TB medication 6 month treatment .</brief_summary>
	<brief_title>Safety Efficacy Trial Delamanid 6 Months Patients With Multidrug Resistant Tuberculosis</brief_title>
	<detailed_description>The purpose trial evaluate efficacy delamanid administer orally 100 mg twice daily ( BID ) 2 month follow 200 mg daily ( QD ) 4 month combination optimize background regimen ( OBR ) versus placebo OBR 6-month intensive phase MDR TB treatment . This trial multicenter , randomize , double-blind , stratified , placebo-controlled trial conduct globally 2 parallel group approximately 18 site 7 country qualify treat MDR TB . In addition , subtrial comprise human immunodeficiency virus ( HIV ) positive patient antiretrovirals ( ARVs ) trial randomize OBR plus placebo OBR plus delamanid conduct site South Africa prequalified integrated approach TB HIV treatment management sufficient population MDR TB patient co-infected HIV enrollment .</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Tuberculosis , Multidrug-Resistant</mesh_term>
	<criteria>Provide write , inform consent Current Diagnosis MDR TB Chest radiograph consistent TB Able produce sputum Negative urine pregnancy test agree use highly effective method birth control and/or adequate method contraception Allergy nitroimidazoles nitroimidazole derivates Diseases condition use nitroimidazoles nitroimidazole derivates contraindicate Use disallow medication Renal impairment Abnormal ECG Cardiovascular disorder BMI &lt; 16 kg/m2 Karnofsky score &lt; 50 % Significant metabolic , gastrointestinal , neurological , psychiatric , endocrine disease , active malignancy Alcohol abuse Pregnant , breastfeeding , plan conceive father child Recent use methadone , benzodiazepine , cocaine , amphetamine/metamphetamine , tetrahydrocannabinol , barbiturate , opiates Previous exposure delamanid Administered IMP within 1 month prior Visit 1 Evidence XDR TB base definition WHO HIV coinfection patient screen site participate HIV subtrial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Multidrug resistant tuberculosis</keyword>
</DOC>